<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04667884</url>
  </required_header>
  <id_info>
    <org_study_id>201911143</org_study_id>
    <nct_id>NCT04667884</nct_id>
  </id_info>
  <brief_title>Effects of Prebiotic or Probiotic Supplements on Symptoms of Functional Constipation</brief_title>
  <official_title>Effects of Prebiotic or Probiotic Supplements on Symptoms of Functional Constipation Among Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Health Science Center of Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Health Science Center of Xi'an Jiaotong University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study intends to evaluate the effects of three prebiotic solid beverages (mainly dietary&#xD;
      fiber and prebiotics) and one probiotic solid beverage on the laxative effect of patients&#xD;
      with functional constipation through randomized controlled trials. The influence of tract&#xD;
      flora is expected to provide a basis for related therapies for patients with functional&#xD;
      constipation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 15, 2020</start_date>
  <completion_date type="Actual">September 30, 2021</completion_date>
  <primary_completion_date type="Actual">May 22, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of bowel movements per week</measure>
    <time_frame>week 0 to 4</time_frame>
    <description>bowel movements will be recorded per week</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Classification of bowel status</measure>
    <time_frame>day 0, 14, 28</time_frame>
    <description>Classification according to the difficulty of defecation 9/5000 According to the difficulty of defecation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bristol classification of stool characteristics</measure>
    <time_frame>day 0, 14, 28</time_frame>
    <description>Bristol classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glucose</measure>
    <time_frame>day 0, 14, 28</time_frame>
    <description>Fasting plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL-C</measure>
    <time_frame>day 0, 14, 28</time_frame>
    <description>Fasting plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL-C</measure>
    <time_frame>day 0, 14, 28</time_frame>
    <description>Fasting plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TG</measure>
    <time_frame>day 0, 14, 28</time_frame>
    <description>Fasting plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tch</measure>
    <time_frame>day 0, 14, 28</time_frame>
    <description>Fasting plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diversity and abundance of intestinal flora</measure>
    <time_frame>day 0, 14, 28</time_frame>
    <description>16s rRNA</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">250</enrollment>
  <condition>Constipation</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a mixture of Xylooligosaccharides, Stachyose, Fructooligosaccharides, and Water-soluble Dietary Fiber, 12 g/d, 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a mixture of Fructooligosaccharide, water-soluble dietary fiber, polydextrose, and isomalt oligosaccharide, 12 g/d, 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a mixture of Polydextrose, wheat fiber, and Seed shell of Plantago rotundifolia, 12 g/d, 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a mixture of Fructooligosaccharides, Bifidobacterium lactis HN019 and Lactobacillus rhamnosus HN001, 3 g/d, 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group E</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Maltodextrin， 3 g/d, 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Prebiotics or Probiotics</intervention_name>
    <description>All the supplements were provided in solid drinks，and required to drink with plain water 35-40℃, and lifestyle intervention was provided to all the groups by reading materials.</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_label>Group D</arm_group_label>
    <arm_group_label>Group E</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adults: 18 to 70 years old (not less than 50% of the final population over 45 years&#xD;
             old, and not less than 30% of men);&#xD;
&#xD;
          2. Patients with functional constipation (refer to Rome IV diagnostic criteria for&#xD;
             functional constipation); * Symptoms appeared for at least 6 months before diagnosis,&#xD;
             and met the above diagnostic criteria in the past 3 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant and lactating women;&#xD;
&#xD;
          2. Unable to take the test sample and complete the inspection items as required due to&#xD;
             inability to take food by mouth, weakness, allergies or other reasons (including the&#xD;
             inability to complete all items due to recent travel plans);&#xD;
&#xD;
          3. Unclear main complaint and obvious abnormal mental state;&#xD;
&#xD;
          4. The liver and kidney function indexes are obviously abnormal (combined with the&#xD;
             results of physical examination within the past 1 year);&#xD;
&#xD;
          5. Acute gastrointestinal diseases occurred in the past month, and constipation caused by&#xD;
             surgical operations in the past month;&#xD;
&#xD;
          6. Take antibiotics, laxatives or topical agents, anticholinergics, antidiarrheals&#xD;
             frequently in the past 1 month, and the frequency is more than 1 time/week&#xD;
&#xD;
          7. Have been diagnosed with the following diseases: cancer (especially cancer of the&#xD;
             digestive tract), severe enteritis, intestinal obstruction, inflammatory bowel&#xD;
             disease, hypothyroidism, mental illness;&#xD;
&#xD;
          8. Have been diagnosed with the following diseases: severe systemic diseases such as&#xD;
             stroke, heart disease, liver cirrhosis, renal failure, hematopoietic system, or&#xD;
             qualitative intestinal diseases caused by colonoscopy or imaging display;&#xD;
&#xD;
          9. In the past 3 months, there are often abdominal pain, abdominal pain accompanied by&#xD;
             changes in bowel characteristics or frequency, blood in the stool, diarrhea or&#xD;
             involuntary weight loss;&#xD;
&#xD;
         10. Clinical manifestations or diseases that other researchers believe are not suitable&#xD;
             for participating in the project.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xin Liu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Health Science Center of Xi'an Jiaotong University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Xi'an Jiaotong University</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710061</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 7, 2020</study_first_submitted>
  <study_first_submitted_qc>December 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 16, 2020</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Health Science Center of Xi'an Jiaotong University</investigator_affiliation>
    <investigator_full_name>Jiaomei Yang</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

